Retour
Fourchette du Jour
8,51 €
8,77 €
Fourchette 52 Semaines
4,16 €
10,94 €
Volume
1 727 566
Moyenne 50J / 200J
8,02 €
/
6,14 €
Clôture Précédente
8,84 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,1 | 0,4 |
| P/B | 1,8 | 2,9 |
| ROE % | -45,7 | 3,9 |
| Net Margin % | -638,9 | 3,8 |
| Rev Growth 5Y % | -50,0 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
21,29 €
+148.4%
Low: 18,00 €
High: 30,00 €
BPA Prévisionnel
-2,04 €
CA Est.
140 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-1,20 €
-1,60 € – -0,75 €
|
250 M | 1 |
| FY2029 |
-1,42 €
-1,90 € – -0,89 €
|
190 M | 1 |
| FY2028 |
-1,63 €
-1,91 € – -1,16 €
|
150 M | 3 |
Points Clés
Revenue declined -49,98% annually over 5 years
Debt/Equity of 0,24 — conservative balance sheet
Negative free cash flow of -396,61M
PEG of 0,11 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 42,37%
Capital efficient — spends only 7,05% of revenue on capex
Croissance
Revenue Growth (5Y)
-49,98%
Revenue (1Y)-7,61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-45,73%
ROIC-36,86%
Net Margin-638,87%
Op. Margin-682,68%
Sécurité
Debt / Equity
0,24
Current Ratio5,54
Interest Coverage0,00
Valorisation
P/E Ratio
-3,13
P/B Ratio1,79
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -7,61% | Revenue Growth (3Y) | -10,81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -49,98% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 68,56M | Net Income (TTM) | -437,99M |
| ROE | -45,73% | ROA | -43,68% |
| Gross Margin | 82,92% | Operating Margin | -682,68% |
| Net Margin | -638,87% | Free Cash Flow (TTM) | -396,61M |
| ROIC | -36,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,24 | Current Ratio | 5,54 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,13 | P/B Ratio | 1,79 |
| P/S Ratio | 19,98 | PEG Ratio | 0,11 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,37B | Enterprise Value | 1,32B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 68,56M | 74,21M | 86,18M | 1,62B | 1,10B |
| Net Income | -437,99M | -521,96M | -615,06M | 515,84M | 528,58M |
| EPS (Diluted) | -3,16 | -3,83 | -4,59 | 3,83 | 3,96 |
| Gross Profit | 56,85M | -404,44M | -486,65M | 994,83M | 581,54M |
| Operating Income | -468,02M | -587,17M | -684,31M | 833,07M | 420,75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,00B | 1,40B | 1,92B | 2,80B | 1,95B |
| Total Liabilities | 237,55M | 248,43M | 328,82M | 724,13M | 522,42M |
| Shareholders' Equity | 765,28M | 1,15B | 1,59B | 2,08B | 1,43B |
| Total Debt | 186,91M | 97,89M | 124,54M | 127,97M | 137,49M |
| Cash & Equivalents | 234,11M | 222,95M | 241,58M | 848,63M | 347,82M |
| Current Assets | 514,08M | 1,04B | 1,59B | 2,52B | 1,56B |
| Current Liabilities | 92,82M | 119,66M | 175,41M | 511,03M | 341,24M |